MACKEY CATHERINE J 4

4 · Voyager Therapeutics, Inc. · Filed Jun 11, 2026

AI-generated summary of this filing

Updated Jun 11, 2026

Voyager (VYGR) Director Catherine Mackey Receives 30,000-Share Award

What Happened

Catherine J. Mackey, a director of Voyager Therapeutics, was granted a stock option award covering 30,000 shares on 2026-06-09. The reported transaction shows $0.00 paid at grant (derivative award), and no shares were sold or purchased outright in this filing.
This grant is a compensation award (transaction code A) rather than an open-market purchase or sale.

Key Details

Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (timely).
Reported price at grant: $0.00; transaction type: Award/Grant of a derivative (option).
Shares owned after transaction: Not specified in the filing excerpt provided.
Footnote: The option was issued under Voyager’s 2025 Stock Incentive Plan per the director compensation policy. Vesting commencement = grant date; all shares vest on the earlier of the one-year anniversary or the next annual meeting of stockholders, subject to continued service.
Remarks: Exhibit 24 (Power of Attorney) included in the filing.

Context

This is a standard director compensation grant, not an exercised option or sale. No cash was exchanged at grant; the economic value will depend on future vesting and any exercise terms and the company’s stock price.
Such grants are routine for non-employee directors and are compensation rather than a direct signal of buying or selling intent.

Form 4

Period: 2026-06-09

Director

Transactions

Award
Stock Option (Right to Buy)
[F1]
2026-06-09+30,000→ 30,000 total
Exercise: $3.43Exp: 2036-06-09→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director.

Signature

/s/ Gregory L. Shiferman, as Attorney-in-Fact for Catherine J. Mackey|2026-06-11

2 files